2m 2m 2m 2m 2m 2m 2m
ROYAL PHARM -A (RPRX)
NASDAQ
$54.85-$0.50 (-0.91%)
Price as of Jun 24, 2026 6:32 PM EDT- $24.5BMarket Cap
- 56.44%1-Year Change
- BiotechnologyIndustry
ROYAL PHARM -A (RPRX)
$54.85-$0.50 (-0.91%)
RPRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $55.35 | ||
Change | +$1.78 (+3.32%) | ||
Open | $53.58 | ||
High | $55.50 | ||
Low | $53.31 | ||
Previous Close | $53.57 | ||
Volume | 4,896,196 | ||
30-Day Average Volume | 4,571,595 | ||
1-Week Change | 2.10% | ||
1-Month Change | 1.56% | ||
1-Year Change | 56.44% | ||
3-Year Change | 93.60% | ||
5-Year Change | 47.51% | ||
Fundamentals | |||
Shares Outstanding | 443.2M | ||
Total Assets | $19.8B | ||
Market Cap | $24.5B | ||
Enterprise Value | $32.9B | ||
Period: QTR TTM FY | |||
Revenue | $595.0M | ||
Net Income | $294.7M | ||
Free Cash Flow | $718.2M | ||
EBIT | $294.7M | ||
EBITDA | $295.9M | ||
Net Working Capital | $890.1M | ||
EPS | $0.67 | ||
Enterprise Value/EBITDA | 111 | ||
Enterprise Value/Revenue | 55 | ||
P/B | 2 | ||
P/E | 83 | ||
PEG | 1 | ||
Price/Free Cash Flow | 34 | ||
Price/Operating Cash Flow | 34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.70% | ||
Trailing Annual Dividend Yield | 1.64% | ||
Ex-Dividend Date | 05/15/2026 | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 10/15/2010 | ||
Earnings & Revenue
Annual Dividend Yield